institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 3 days ago • loading... • Updated 3 days ago

Marengo Presents Monotherapy Activity of Invikafusp Alfa_ a First-in-Class Selective Dual T Cell Agonist in ...

Summary by World News

Promising monotherapy activity observed in

11 Articles

11 Articles

All

Left

2

Center

3

Right

1

+9 Reposted by 9 other sources

Marengo Presents Monotherapy Activity of Invikafusp Alfa, a First-in-Class Selective Dual T Cell Agonist in PD-1 Resistant GI Tumors, as a Late-Breaking Oral Presentation at ESMO Gastrointestinal Cancers Congress 2025

Promising monotherapy activity observed in all three major metastatic colorectal cancer subtypes harboring high tumor mutational burden (MSS RASwt, MSS RASmut...

3 days ago·United States

Read Full Article

Marengo Presents Monotherapy Activity of Invikafusp Alfa_ a First-in-Class Selective Dual T Cell Agonist in ...

Promising monotherapy activity observed in

3 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources11

Leaning Left2Leaning Right1Center3Last Updated2 days agoBias Distribution

50% Center

Bias Distribution

50% of the sources are Center

50% Center

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

World News broke the news in United States 3 days ago on Wednesday, July 2, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics

You have read 1 out of your 5 free daily articles.